Climbing RAS, the everest of oncogenes
- PMID: 24402942
- DOI: 10.1158/2159-8290.CD-13-0906
Climbing RAS, the everest of oncogenes
Abstract
Mutations that activate the small GTP-binding protein KRAS are the most common oncogenic event in human tumors. Thirty years after its discovery, mutant KRAS has yet to be therapeutically conquered.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous
